(Press-News.org) CHICAGO – A study of more than 33,000 outpatient male veterans suggests that a longer duration of antimicrobial treatment of more than seven days for a urinary tract infection (UTI) appeared not to be associated with a reduced risk of early or late recurrence compared to a shorter duration (seven days or less) of treatment, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
The optimal treatment duration for UTI in ambulatory, noncatheterized women is well defined, but the optimal treatment duration in men is unknown. Duration of antimicrobial treatment is important because an insufficient treatment duration can lead to recurrent disease, but prolonged treatment can increase costs, promote antimicrobrial resistance and increase the risk of Clostridium difficile infection (CDI, which can be contracted after prolonged use of antibiotics), according to the study background.
Dimitri M. Drekonja, M.D., M.S., and colleagues with the Minneapolis Veterans Affairs Health Care System, Minnesota, used administrative data from the Veterans Affairs Computerized Patient Record System to evaluate treatment patterns for male UTI among outpatients and to assess the association between treatment duration and outcomes, including UTI recurrence and CDI.
Researchers identified 39,149 UTI episodes involving 33,336 unique patients, including 33,336 index cases (85.2 percent), 1,772 early recurrences (4.5 percent) and 4,041 late recurrences (10.3 percent), according to the study results. Patients had an average age of 68 years.
"We found that two drugs (ciprofloxacin and trimethoprim-sulfamethoxazole) were used to treat most male UTI episodes and that the treatment duration varied substantially within the recommended seven to 14 days (84.4 percent of patients) and outside of this range (15.6 percent of patients). Most important, compared with shorter-duration treatment (≤7 days), longer-duration treatment (>7 days) exhibited no association with a reduced risk for early or late recurrence," the authors comment.
Of the index UTI cases, 4.1 percent were followed by early recurrence and 9.9 percent by late recurrence. While longer-duration of treatment was not associated with a reduction in early or late recurrence, it was associated with increased late recurrence compared with shorter-duration treatment (10.8 percent vs. 8.4 percent). Also, C difficile infection risk was higher with longer-duration vs. shorter-duration treatment (0.5 percent vs. 0.3 percent), according to the study results.
Researchers suggest their findings "question the role" of longer-duration treatment for male UTI in the outpatient setting.
"A randomized trial is needed to directly assess the benefits and harms of shorter-duration vs. longer-duration treatment for male UTI," the authors conclude.
(Arch Intern Med. Published online December 3, 2012. doi:10.1001/2013/jamainternmed.829. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: This study was supported by the resources of the Minneapolis Veterans Affairs Health Care System, including the Center for Epidemiological and Clinical Research and the Center for Chronic Disease Outcomes Research. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Research Letter: Preoperative Urine Cultures at a Veterans Affairs Medical Center
In a related research letter, Dimitri M. Drekonja, M.D., M.S., of the Minneapolis Veterans Affairs Health Care System, Minnesota, and colleagues suggest that preoperative cultures (UCs) of urine are ordered inconsistently and that treatment of preoperative bacteriuria appears to be associated with no benefit, based on a review of medical records for patients undergoing 1,934 cardiothoracic, orthopedic and vascular procedures (Online First).
(Arch Intern Med. Published online December 3, 2012. doi:10.1001/2013/jamainternmed.834. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: This study was supported by the resources of the Minneapolis Veterans Affairs Health Care System, including the Center for Epidemiological and Clinical Research and the Center for Chronic Disease Outcomes Research. Another author also disclosed support. One author also made a conflict of interest disclosure with research grants or contracts with Merck, Rochester Medical and Syntiron. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: New Perspectives on Urinary Tract Infection in Men
In an accompanying commentary, Barbara W. Trautner, M.D., Ph.D., of the Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas, writes: "Most studies on the treatment of acute urinary tract infection (UTI) in outpatients have been performed in women, usually premenopausal women."
"What both studies can do, and indeed do effectively, is to call into question current treatment practices concerning bacteriuria in men," Trautner continues. "We recommend a culture shift in antibiotic prescribing practices for men with bacteriuria from 'more is better' to 'less is more.' Widespread antimicrobial resistance, appreciation of the human microbiome, outbreaks of CDI [Clostridium difficile infection], and emphasis on cost-effective care discourage the indiscriminate use of antibiotics."
"On the other hand, the studies commented on herein encourage more judicious use of antibiotics by failing to find evidence of clinical benefit with longer courses of antibiotics or with additional courses of preoperative antibiotics. As we continue to explore UTI in the male half of the population, these articles are a timely reminder that standard practice is not always best practice and that critical thinking is required to recognize the difference," Trautner concludes.
(Arch Intern Med. Published online December 3, 2012. doi:10.1001/.jamainternmed.2013.1783. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
To contact study and research letter author Dimitri M. Drekonja, M.D., M.S., call Ralph Heussner at 612-467-3012 or email ralph.heussner@va.gov. To contact invited commentary author Barbara W. Trautner, M.D., Ph.D., call Dipali Pathak at 713-798-6826 or email pathak@bcm.edu.
END
CHICAGO – A survey finds that 14.2 percent of adolescents ages 13 to 18 years with any mental disorder reported being treated with a psychotropic medication in the last 12 months, which researchers suggest challenges concerns about widespread overmedication and misuse of psychotropic medications among young people in the U.S., according to a study published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.
Concern has been raised about inappropriate prescribing of psychotropic medications to children and adolescents, but these criticisms ...
A special collection of articles about the Deepwater Horizon oil spill provides the first comprehensive analysis and synthesis of the science used in the unprecedented response effort by the government, academia, and industry. Papers present a behind-the-scenes look at the extensive scientific and engineering effort—teams, data, information, and advice from within and outside the government—assembled to respond to the disaster. And, with the benefit of hindsight and additional analyses, these papers evaluate the accuracy of the information that was used in real-time to ...
New research helps explain why some teenagers are more prone to drinking alcohol than others. The study, led by King's College London's Institute of Psychiatry (IoP) and published in Proceedings of National Academy of Sciences (PNAS) provides the most detailed understanding yet of the brain processes involved in teenage alcohol abuse.
Alcohol and other addictive drugs activate the dopamine system in the brain which is responsible for feelings of pleasure and reward. Recent studies from King's IoP found that the RASGRF2 gene is a risk gene for alcohol abuse, however, the ...
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
Stroke is when part of the neural tissue in the brain is damaged due to lack of oxygen delivery, either ...
Federal support for health security research is heavily weighted toward preparing for bioterrorism and other biological threats, providing significantly less funding for challenges such as monster storms or attacks with conventional bombs, according to a new RAND Corporation study.
The findings, published in the December issue of the journal Health Affairs, come from the first-ever inventory of national health security-related research funded by civilian agencies of the federal government.
Researchers say recent events such as Superstorm Sandy, tornadoes in the Midwest ...
Immigrants who come to the United States from Mexico arrive with a significant amount of undiagnosed disease, tempering previous findings that immigrants are generally healthier than native-born residents, according to a new study.
About half of recent Mexican immigrants who have diabetes are unaware they have the disease and about one-third of those with high blood pressure are unaware of the illness, according to findings published in the December edition of the journal Health Affairs.
The undiagnosed disease explains about one-third of the "healthy immigrant effect" ...
AMHERST, Mass. – Inside many growing cells, an active transport system runs on nano-sized microtubule tracks that resemble a highway, complete with motors carrying cargo quickly from a central supply depot to growing tips or wherever materials are needed. In spite of the cell's busy, high-traffic environment, researchers know the system somehow works efficiently, without accidents or traffic jams.
Now a team of biophysicists at the University of Massachusetts Amherst, using a special technique and unique microscope, have improved upon earlier studies that used too-simple ...
Recent studies have noticed a strong positive correlation between the concentration of nitrogen in forests and infrared reflectance measured from aircraft and satellites. Some scientists have suggested this demonstrates a previously overlooked role for nitrogen in regulating the earth's climate system.
However, a new paper in Proceedings of the National Academy of Sciences, shows that the apparent relationship between leaves' nitrogen levels and infrared reflection is spurious and it is in fact the structure of forest canopies (the spatial arrangement of the leaves) that ...
Parents whose children move far away from home are less likely to become depressed than parents with children living nearby, according to a new study of rural districts in Thailand. The study, led by scientists at King's College London, suggests that children who migrate to urban areas are more likely to financially support their parents, which may be a factor for lower levels of depression.
Dr Melanie Abas, lead author from the Institute of Psychiatry at King's said: 'Parents whose children had all left the district were half as likely to be depressed as parents who ...
ALEXANDRIA, Va. — The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major achievements in precision medicine, cancer screening and overcoming treatment resistance.
"Consistent, significant achievements are being made in oncology care with novel therapeutics, even in malignancies that have previously had few treatment options, as well as defining factors that will predict for response to treatment. ASCO's ...
